Thomas Sanchez, MD
Anesthesiology · Lihue, HINPI 1841395522
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,287 of the $2,868 with a category attached, or 79.7%. 38 manufacturers reported payments, led by Medtronic at 24.0% of the total. Reporting peaked in 2021 at $968 and has fallen 52.4% since, to $461 in 2025. Among anesthesiology clinicians in HI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 102 payments — averaging $28.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$689
- AbbVie$343
- Nevro Corp.$201
- Argenx US, Inc.$147
- Teva Pharmaceuticals USA, Inc.$131
- Eisai Inc.$118
- plus $1K from 32 others
What the payments were for
- Travel & lodging$58220%
- Food & beverage$2,28780%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 4 | $689 |
| AbbVie(2 entities) | 13 | $343 |
| Nevro Corp. | 8 | $201 |
| Argenx US, Inc. | 6 | $147 |
| Teva Pharmaceuticals USA, Inc. | 6 | $131 |
| Eisai Inc. | 5 | $118 |
| Globus Medical | 1 | $78 |
| Sanofi | 4 | $67 |
| AstraZeneca | 4 | $65 |
| Neurelis, Inc. | 3 | $65 |
| Sunovion Pharmaceuticals Inc. | 4 | $64 |
| Lundbeck LLC | 3 | $61 |
| Greenwich Biosciences, Inc. | 2 | $56 |
| Portola Pharmaceuticals, LLC | 2 | $55 |
| Biogen | 3 | $55 |
| EMD Serono, Inc. | 2 | $53 |
| Lilly USA, LLC | 2 | $49 |
| Avadel CNS Pharmaceuticals, LLC | 2 | $46 |
| Amylyx Pharmaceuticals, Inc. | 2 | $44 |
| Amgen | 2 | $40 |
| Novartis | 2 | $38 |
| Genentech USA, Inc. | 2 | $37 |
| Jazz Pharmaceuticals Inc. | 2 | $36 |
| GE HealthCare | 2 | $35 |
| Acadia Pharmaceuticals Inc | 2 | $30 |
| Catalyst Pharmaceuticals, Inc. | 1 | $27 |
| UCB, Inc. | 2 | $27 |
| Merz Pharmaceuticals, LLC | 1 | $25 |
| TMS Neurohealth Centers Inc. | 1 | $25 |
| Sarepta Therapeutics, Inc. | 1 | $24 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
| Banner Life Sciences, LLC | 1 | $21 |
| Pfizer | 1 | $20 |
| GRT US Holding, Inc. | 1 | $19 |
| Si-bone, Inc. | 1 | $18 |
| Neurocrine Biosciences, Inc. | 1 | $17 |
| Inspire Medical Systems, Inc. | 1 | $13 |
| Amneal Pharmaceuticals LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTELLIS$582
How this compares
$2,868 in reported general payments places this provider in the 95th percentile of 186 anesthesiology providers in Hawaii.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| UbrelvyUbrogepant | 14 | $14,637 |
| Lidocaine | 23 | $2,043 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 38 | $1,034 |
| Ondansetron OdtOndansetron | 23 | $869 |
| Pregabalin | 47 | $655 |
| Oxycodone Hcl | 36 | $517 |
| Baclofen | 33 | $478 |
| Morphine Sulfate ErMorphine Sulfate | 12 | $478 |
| Gabapentin | 26 | $376 |
| Celecoxib | 20 | $366 |
| Hydromorphone Hcl | 23 | $303 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 18 | $286 |
| Diclofenac Sodium | 18 | $284 |
| Pramipexole DihydrochloridePramipexole Di-Hcl | 11 | $160 |
| Meloxicam | 18 | $101 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieUbrelvy | $343 | $14,63714 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 186 anesthesiology providers in Hawaii.
Other anesthesiology in Lihue
- Matthew RuelLihue$1K
- Jennifer WhiteLihue$181
- Josianna HensonKahului$18K
- Mary SchaeferKailua$11K
- William RheeKealakekua$9K
- Clifford CharHonolulu$6K
- Oren BernsteinHonolulu$3K
- Carl HoHonolulu$3K
- Nicole MorikawaHonolulu$2K
- Adam AritaHonolulu$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.